Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia
Clinical trial NCT06223919 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06223919
- Sponsor
- Universidad Nacional de Colombia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-16
- Primary completion
- 2024-08-20
- Enrollment
- 8686
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.